多模态影像揭示老年APOE2携带者选择性淀粉样蛋白负荷降低
该横断面多模态神经影像研究纳入572名无痴呆老年人,比较APOE2携带者与APOE3纯合子的区域淀粉样蛋白负荷、葡萄糖代谢和灰质体积。结果显示APOE2携带者 precuneal 淀粉样蛋白病理显著更少,且未出现年龄相关的淀粉样蛋白增加,而代谢和海马体积无差异。
要点
- APOE2携带者 precuneal 淀粉样蛋白负荷显著低于APOE3纯合子。
- APOE2携带者未显示典型的年龄相关淀粉样蛋白增加。
- APOE2对 parieta 代谢和海马体积无显著影响。
核心结论
- 在研究所考虑的阿尔茨海默病生物标志物范围内,APOE2等位基因似乎对老年大脑中淀粉样蛋白病理积累的减少具有相对选择性的效应。
研究设计与样本
- 横断面多模态神经影像研究,纳入572名无痴呆老年人(认知正常和轻度认知障碍),来自阿尔茨海默病神经影像学倡议。
- 使用AV45-PET评估区域淀粉样蛋白负荷,氟脱氧葡萄糖-PET评估葡萄糖代谢,结构MRI评估灰质体积。
- 比较APOE2携带者与风险中性APOE3纯合子,控制年龄、性别、教育和临床诊断。
主要发现
- 基于感兴趣区的分析中,APOE2携带者 precuneal 淀粉样蛋白病理显著更少,且未显示典型的年龄相关淀粉样蛋白负荷增加,但年龄×基因型交互作用仅趋势显著。
- parieta 代谢和海马体积在APOE2与APOE3基因型间无差异,两组均显示年龄对这些标志物的 comparable 负面影响。
- 空间无偏的体素分析显示广泛淀粉样蛋白沉积减少,但灰质体积或代谢无差异;脑脊液生物标志物分析显示对淀粉样蛋白有显著效应但对tau病理无显著效应。
临床怎么用
- 对于老年APOE2携带者,应关注其淀粉样蛋白负荷较低的特点,但代谢和海马体积变化与APOE3纯合子相似。
局限性
- 年龄×基因型交互作用仅趋势显著。
- 横断面设计无法推断因果。
- 样本来自特定队列,可能限制泛化性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To comprehensively assess neurobiological effects of the protective APOE2 allele in the aged brain using a cross-sectional multimodal neuroimaging approach. METHODS: Multimodal neuroimaging data were obtained from a total of 572 older individuals without dementia (cognitively normal and mild cognitive impairment) enrolled in the Alzheimer's Disease Neuroimaging Initiative and included assessments of regional amyloid load with AV45-PET, glucose metabolism with fluorodeoxyglucose-PET, and gray matter volume with structural MRI. Imaging indexes of APOE2 carriers were contrasted to risk-neutral APOE3 homozygotes, and analyses were controlled for age, sex, education, and clinical diagnosis. Additional models examined genotype-specific effects of age on the imaging markers. RESULTS: In region-of-interest-based analyses, APOE2 carriers had significantly less precuneal amyloid pathology and did not show the typical age-related increase in amyloid load, although the age × genotype interaction was only trend-level significant. In contrast, parietal metabolism and hippocampal volume did not differ between APOE2 and APOE3 genotypes, and both groups showed comparable negative effects of age on these markers. The amyloid specificity of APOE2-related brain changes was corroborated in 2 complementary analyses: spatially unbiased voxel-wise analyses showing widespread reductions in amyloid deposition but no differences in gray matter volume or metabolism and an analysis of CSF-based biomarkers showing a significant effect on amyloid but not on tau pathology. CONCLUSIONS: Regarding the range of Alzheimer disease biomarkers considered in the present study, the APOE2 allele appears to have a relatively selective effect on reduced accumulation of amyloid pathology in the aged brain.
引用
- Grothe MJ, Villeneuve S, Dyrba M, et al. Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology. 2017. PMID: 28062720. doi:10.1212/WNL.0000000000003585
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。